WISC Partners
VC Fund
Madison, United States
WISC Partners is a VC fund in Madison focused on Health Care and Medical. WISC Partners provides Strategic Operating Capital to entrepreneurs who have the potential to build great companies.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 44%
- Fund size:
- $8.2M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries WISC Partners invests in
Stages WISC Partners invests in
Countries WISC Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Investment Focus
Industry
- Health Care 4 (22%)
- Medical 3 (17%)
- Medical Device 2 (11%)
- Music 1 (6%)
- Sales 1 (6%)
Stage
- Funding Round 4 (22%)
- Seed 2 (11%)
- Series A 2 (11%)
- Debt Financing 2 (11%)
- Series B 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allen Dines
Executive Advisor
|
Executive Advisor | Total investments: 0 | Find email | |
Cameron Ackbury
Venture Capital Executive Partner
|
Venture Capital Executive Partner | Total investments: 0 | Find email | |
Craig Johnson
Executive Partner
|
Executive Partner | Total investments: 0 | Find email | |
Joni Kahn
LP Committee Member
|
LP Committee Member | Total investments: 0 | Find email | |
Mike Splinter
General Partner & Founder
|
General Partner & Founder | Total investments: 1 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Rehabpulse is revolutionizing the access to medical products that enhance people's lives. The company was founded in 2019 and is headquartered in Middleton, Wisconsin. | $4.5M / Venture - Series Unknown / Oct 20, 2021 | ||
| Wellbe develops a cloud-based platform that facilitates connected care between patients and healthcare providers. It empowers patients to participate as active partners in their treatment and giving providers the ability to monitor large numbers of patients more effectively.The company was founded in 2009 and is headquartered in Madison,Wisconsin. | $2M / Series A / Aug 31, 2021 | ||
| Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, andideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management. | $4M / Series A / Nov 05, 2019 | ||
| The PegEx Platform is a waste management platform ideally suited for waste generators, brokers, haulers, and disposal facilities. The PegEx cloud-based Platform allows you to gain liability control of your waste streams and jobs Anytime. Anywhere. | $4M / Series B / May 04, 2018 | ||
| Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, andideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management. | $1.6M / Seed / Jan 02, 2018 | ||
| Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, andideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management. | $1.6M / Dec 28, 2017 | ||
| Wellbe develops a cloud-based platform that facilitates connected care between patients and healthcare providers. It empowers patients to participate as active partners in their treatment and giving providers the ability to monitor large numbers of patients more effectively.The company was founded in 2009 and is headquartered in Madison,Wisconsin. | $400K / May 08, 2017 | ||
| Murfie is an online platform for buying, selling, and trading music collections with remote storage and digital access. The company offers a buying, selling, and trading community for music lovers who want traditional ownership with the convenience of remote storage and digital access.It was founded in 2010 and is headquartered in Madison,Wisconsin. | $623.3K / Jan 01, 2017 | ||
| Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, andideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management. | $600K / Debt Financing / Aug 18, 2016 | ||
| Murfie is an online platform for buying, selling, and trading music collections with remote storage and digital access. The company offers a buying, selling, and trading community for music lovers who want traditional ownership with the convenience of remote storage and digital access.It was founded in 2010 and is headquartered in Madison,Wisconsin. | $8.2M / Jul 02, 2016 | ||
| See all 18 investments → | |||
Co-Investors
Formidable Asset Management
1 deal together
HealthX Ventures
1 deal together
MDC Ventures
1 deal together
Capital Midwest Fund
1 deal together
N29 Capital Partners
1 deal together
Plymouth Growth
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does WISC Partners invest in?
WISC Partners invests primarily in Health Care, Medical and Medical Device startups, most often at Funding Round and Seed stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact WISC Partners?
Public channels for WISC Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at WISC Partners?
The team at WISC Partners includes Allen Dines (Executive Advisor), Cameron Ackbury (Venture Capital Executive Partner) and Craig Johnson (Executive Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
